Jotaro Harada
Overview
Explore the profile of Jotaro Harada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
0
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Harada J, Kawashima K, Matsubara Y, Oshi M, Sasamoto M, Yamada A, et al.
Pathol Res Pract
. 2025 Mar;
269:155872.
PMID: 40023141
Purpose: Enhancer of zeste homolog 2 (EZH2) is highly expressed in triple-negative breast cancer (TNBC) and induces massive histone modification via trimethylation at lysine 27 of histone H3 (H3K27me3). The...
2.
Numata Y, Uemura K, Tatenuma T, Ito H, Komeya M, Ito Y, et al.
Hinyokika Kiyo
. 2025 Jan;
70(12):451-456.
PMID: 39763075
A 28-year-old male presented to his physician with a chief complaint of fever and cough. Contrastenhanced computed tomography revealed a 17×16×8 cm heterogeneous tumor in the anterior mediastinum, as well...
3.
Kurita Y, Kubota K, Harada J, Honda Y, Yamazaki Y, Iizuka T, et al.
J Hepatobiliary Pancreat Sci
. 2024 Dec;
PMID: 39639754
Background: The choice between 22-gauge endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) and EUS-guided fine-needle aspiration (EUS-FNA) for histological diagnosis of type 1 autoimmune pancreatitis (AIP) is unclear. We retrospectively examined the...
4.
Crucial immunological roles of the invasion front in innate and adaptive immunity in cervical cancer
Hirahara Y, Shimizu K, Yamasaki S, Iyoda T, Ueda S, Sato S, et al.
Br J Cancer
. 2024 Oct;
131(11):1762-1774.
PMID: 39472714
Background: The immunostimulatory actions of innate and adaptive immune responses play a crucial role in the cancer-immunity cycle. Although cervical cancer (CC) exhibits a high recurrence rate, the relation with...
5.
Takahashi Y, Iijima T, Ishidera Y, Imai Y, Mizushima T, Utsunomiya D, et al.
Case Rep Oncol
. 2024 Aug;
17(1):882-890.
PMID: 39144241
Introduction: Primary small bowel carcinoma in pregnant women is extremely rare. Small bowel cancer is difficult to diagnose because of its rarity, lack of specific clinical symptoms, and particular anatomical...
6.
Ishiga K, Kobayashi R, Kanaoka T, Harada J, Kato I, Fujii S, et al.
CEN Case Rep
. 2024 Apr;
13(5):416-418.
PMID: 38656748
No abstract available.
7.
Ishiga K, Kobayashi R, Kanaoka T, Harada J, Kato I, Fujii S, et al.
CEN Case Rep
. 2024 Mar;
13(5):408-415.
PMID: 38453804
A 74-year-old Japanese male with lung squamous cell carcinoma received his first dose of immune checkpoint inhibitors (ICIs): ipilimumab and nivolumab. He developed acute kidney injury (AKI) and was admitted...
8.
Harada J, Horiguchi S, Ishiba T, Kubota H, Ichida M, Sakurai N, et al.
Int J Surg Pathol
. 2020 Dec;
29(5):538-542.
PMID: 33289419
Adenomyoepithelioma (AME) of the male breast is a rare tumor characterized by biphasic proliferation of gland epithelial cells and myoepithelial cells. Though pleomorphic adenoma (PA) is also known to be...